Benjamin I Laufer1,2,3, J Antonio Gomez1,2,3, Julia M Jianu1,2,3, Janine M LaSalle4,5,6. 1. Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA, 95616, USA. 2. Genome Center, University of California, Davis, CA, 95616, USA. 3. MIND Institute, University of California, Davis, CA, 95616, USA. 4. Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA, 95616, USA. jmlasalle@ucdavis.edu. 5. Genome Center, University of California, Davis, CA, 95616, USA. jmlasalle@ucdavis.edu. 6. MIND Institute, University of California, Davis, CA, 95616, USA. jmlasalle@ucdavis.edu.
Abstract
BACKGROUND: Down syndrome (DS) is characterized by a genome-wide profile of differential DNA methylation that is skewed towards hypermethylation in most tissues, including brain, and includes pan-tissue differential methylation. The molecular mechanisms involve the overexpression of genes related to DNA methylation on chromosome 21. Here, we stably overexpressed the chromosome 21 gene DNA methyltransferase 3L (DNMT3L) in the human SH-SY5Y neuroblastoma cell line and assayed DNA methylation at over 26 million CpGs by whole genome bisulfite sequencing (WGBS) at three different developmental phases (undifferentiated, differentiating, and differentiated). RESULTS: DNMT3L overexpression resulted in global CpG and CpG island hypermethylation as well as thousands of differentially methylated regions (DMRs). The DNMT3L DMRs were skewed towards hypermethylation and mapped to genes involved in neurodevelopment, cellular signaling, and gene regulation. Consensus DNMT3L DMRs showed that cell lines clustered by genotype and then differentiation phase, demonstrating sets of common genes affected across neuronal differentiation. The hypermethylated DNMT3L DMRs from all pairwise comparisons were enriched for regions of bivalent chromatin marked by H3K4me3 as well as differentially methylated sites from previous DS studies of diverse tissues. In contrast, the hypomethylated DNMT3L DMRs from all pairwise comparisons displayed a tissue-specific profile enriched for regions of heterochromatin marked by H3K9me3 during embryonic development. CONCLUSIONS: Taken together, these results support a mechanism whereby regions of bivalent chromatin that lose H3K4me3 during neuronal differentiation are targeted by excess DNMT3L and become hypermethylated. Overall, these findings demonstrate that DNMT3L overexpression during neurodevelopment recreates a facet of the genome-wide DS DNA methylation signature by targeting known genes and gene clusters that display pan-tissue differential methylation in DS.
BACKGROUND: Down syndrome (DS) is characterized by a genome-wide profile of differential DNA methylation that is skewed towards hypermethylation in most tissues, including brain, and includes pan-tissue differential methylation. The molecular mechanisms involve the overexpression of genes related to DNA methylation on chromosome 21. Here, we stably overexpressed the chromosome 21 gene DNA methyltransferase 3L (DNMT3L) in the human SH-SY5Y neuroblastoma cell line and assayed DNA methylation at over 26 million CpGs by whole genome bisulfite sequencing (WGBS) at three different developmental phases (undifferentiated, differentiating, and differentiated). RESULTS: DNMT3L overexpression resulted in global CpG and CpG island hypermethylation as well as thousands of differentially methylated regions (DMRs). The DNMT3L DMRs were skewed towards hypermethylation and mapped to genes involved in neurodevelopment, cellular signaling, and gene regulation. Consensus DNMT3L DMRs showed that cell lines clustered by genotype and then differentiation phase, demonstrating sets of common genes affected across neuronal differentiation. The hypermethylated DNMT3L DMRs from all pairwise comparisons were enriched for regions of bivalent chromatin marked by H3K4me3 as well as differentially methylated sites from previous DS studies of diverse tissues. In contrast, the hypomethylated DNMT3L DMRs from all pairwise comparisons displayed a tissue-specific profile enriched for regions of heterochromatin marked by H3K9me3 during embryonic development. CONCLUSIONS: Taken together, these results support a mechanism whereby regions of bivalent chromatin that lose H3K4me3 during neuronal differentiation are targeted by excess DNMT3L and become hypermethylated. Overall, these findings demonstrate that DNMT3L overexpression during neurodevelopment recreates a facet of the genome-wide DS DNA methylation signature by targeting known genes and gene clusters that display pan-tissue differential methylation in DS.
Authors: Meaghan J Jones; Pau Farré; Lisa M McEwen; Julia L Macisaac; Kim Watt; Sarah M Neumann; Eldon Emberly; Max S Cynader; Naznin Virji-Babul; Michael S Kobor Journal: BMC Med Genomics Date: 2013-12-27 Impact factor: 3.063
Authors: Andrew A Lane; Bjoern Chapuy; Charles Y Lin; Trevor Tivey; Hubo Li; Elizabeth C Townsend; Diederik van Bodegom; Tovah A Day; Shuo-Chieh Wu; Huiyun Liu; Akinori Yoda; Gabriela Alexe; Anna C Schinzel; Timothy J Sullivan; Sébastien Malinge; Jordan E Taylor; Kimberly Stegmaier; Jacob D Jaffe; Michael Bustin; Geertruy te Kronnie; Shai Izraeli; Marian H Harris; Kristen E Stevenson; Donna Neuberg; Lewis B Silverman; Stephen E Sallan; James E Bradner; William C Hahn; John D Crispino; David Pellman; David M Weinstock Journal: Nat Genet Date: 2014-04-20 Impact factor: 38.330
Authors: Anshul Kundaje; Wouter Meuleman; Jason Ernst; Misha Bilenky; Angela Yen; Alireza Heravi-Moussavi; Pouya Kheradpour; Zhizhuo Zhang; Jianrong Wang; Michael J Ziller; Viren Amin; John W Whitaker; Matthew D Schultz; Lucas D Ward; Abhishek Sarkar; Gerald Quon; Richard S Sandstrom; Matthew L Eaton; Yi-Chieh Wu; Andreas R Pfenning; Xinchen Wang; Melina Claussnitzer; Yaping Liu; Cristian Coarfa; R Alan Harris; Noam Shoresh; Charles B Epstein; Elizabeta Gjoneska; Danny Leung; Wei Xie; R David Hawkins; Ryan Lister; Chibo Hong; Philippe Gascard; Andrew J Mungall; Richard Moore; Eric Chuah; Angela Tam; Theresa K Canfield; R Scott Hansen; Rajinder Kaul; Peter J Sabo; Mukul S Bansal; Annaick Carles; Jesse R Dixon; Kai-How Farh; Soheil Feizi; Rosa Karlic; Ah-Ram Kim; Ashwinikumar Kulkarni; Daofeng Li; Rebecca Lowdon; GiNell Elliott; Tim R Mercer; Shane J Neph; Vitor Onuchic; Paz Polak; Nisha Rajagopal; Pradipta Ray; Richard C Sallari; Kyle T Siebenthall; Nicholas A Sinnott-Armstrong; Michael Stevens; Robert E Thurman; Jie Wu; Bo Zhang; Xin Zhou; Arthur E Beaudet; Laurie A Boyer; Philip L De Jager; Peggy J Farnham; Susan J Fisher; David Haussler; Steven J M Jones; Wei Li; Marco A Marra; Michael T McManus; Shamil Sunyaev; James A Thomson; Thea D Tlsty; Li-Huei Tsai; Wei Wang; Robert A Waterland; Michael Q Zhang; Lisa H Chadwick; Bradley E Bernstein; Joseph F Costello; Joseph R Ecker; Martin Hirst; Alexander Meissner; Aleksandar Milosavljevic; Bing Ren; John A Stamatoyannopoulos; Ting Wang; Manolis Kellis Journal: Nature Date: 2015-02-19 Impact factor: 69.504
Authors: Maite Mendioroz; Catherine Do; Xiaoling Jiang; Chunhong Liu; Huferesh K Darbary; Charles F Lang; John Lin; Anna Thomas; Sayeda Abu-Amero; Philip Stanier; Alexis Temkin; Alexander Yale; Meng-Min Liu; Yang Li; Martha Salas; Kristi Kerkel; George Capone; Wayne Silverman; Y Eugene Yu; Gudrun Moore; Jerzy Wegiel; Benjamin Tycko Journal: Genome Biol Date: 2015-11-25 Impact factor: 13.583
Authors: Anthony P Brown; Lucy Cai; Benjamin I Laufer; Lisa A Miller; Janine M LaSalle; Hong Ji Journal: Environ Int Date: 2021-11-24 Impact factor: 9.621
Authors: Henriette O'Geen; Marketa Tomkova; Jacquelyn A Combs; Emma K Tilley; David J Segal Journal: Nucleic Acids Res Date: 2022-04-08 Impact factor: 16.971